NCT02265224View on ClinicalTrials.gov

Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC)

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
no Condition
Interventions
DRUG

N-acetylcysteine

The product was administered according to the randomisation list and cross-over design, with 150 mL of still mineral water under fasting conditions on study day 1 of periods 1 or 2 at 8:00±1 h.

All Listed Sponsors
lead

Zambon SpA

INDUSTRY

NCT02265224 - Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC) | Biotech Hunter | Biotech Hunter